To promote the exchange and dissemination of knowledge concerning the diagnosis and treatment of haematopoietic and lymphoid systems diseases, the European Association for Haematopathology has and continues to realise joint meetings together with the Society for Hematopathology, as presented in the following table.
| Year | Venue | BM Symposium | BM Workshop | Lymphoma Symposium | Lymhoma Workshop |
| 2010 | Uppsala | From molecular and histopathological bone marrow studies to therapy | Unusual acute leukemias, Transformation of MPN and MDS, Myelosarcomas and other cases. | Frontiers in diagnosing lymphoma – early lesions, molecular pathogenesis and targeted therapy | Early lesions in lymphoid neoplasia |
| 2011 | Marina del Rey | Cutaneous lymphoma | |||
| 2012 | Lisbon | Reactive and neoplastic T-cell proliferations in the bone marrow | Aggressive mature T/NK cell lymphomas, T-cell prolymphocytic leukaemia and other T-cell proliferations and Bone Marrow Failure. | Peripheral T and NK-cell lymphomas and their mimics; taking a step forward | Peripheral T and NK-cell lymphomas and their mimics |
| 2013 | Houston,
MD Anderson |
Progress in Acute Myeloid Leukemia, Myelodysplastic Syndromes and Acute Lymphoblastic Leukemia:
Classification and Molecular Pathogenesis |
|||
| 2014 | Istanbul | Small B-cell lymphoid neoplasms in bone marrow: diagnostic advances. | Diagnostic difficulties in CLL, Bone marrow manifestations of LPL, MZL, SRPL, HCL-v and HCL, Small B-cell lymphomas in bone marrow multiclonality and composite lymphomas | Redefining the spectrum of small B-cell lymphomas in light of current technology
|
Small B-cell lymphoma |
| 2015 | Long Beach, Stanford | Immunodeficiency and Dysregulation related LPDs | |||
| 2016 | Basel | Aggressive Malignancies of the ‘Other Cells’ of the bone marrow: Histiocytes, Dendritic Cells and Mast Cells” | Aggressive Malignancies of the ‘Other Cells’ of the bone marrow: Histiocytes, Dendritic Cells and Mast Cells” | Aggressive lymphoid and accessory/histiocytic cell neoplasms | Aggressive lymphoid and accessory/histiocytic cell neoplasms |
| 2017 | Chicago | Molecular Genetics in the Diagnosis and Biology of Lymphoid Neoplasms | |||
| 2018 | Edinburgh | ALL and reactive lesions, T-NHL and Hodgkin Lymphoma, Aggressive B-NHL | ALL and reactive lesions, T-NHL and Hodgkin Lymphoma, Aggressive B-NHL | The impact of intrinsic and extrinsic factors in site-specific
lymphoproliferations. |
Extranodal lymphoproliferations, including immune privileged sites |
| 2019 | Phoenix | Addressing the Challenges of Eosinophilia & Mastocytosis | |||
| 2021 | Virtual | Overlaps, borderlines and mimics | Pediatric myeloid neoplasms and related diseases, AML of ambiguous linage, other cases of acute leukemia hard to classify, myelofibrotic myeloid neoplasms | Overlaps, borderlines and mimics:
Understanding lymphoma biology is key to pathological classification and treatment. |
Classic Hodgkin lymphoma and its mimics, spectrum of mediastinal LBCL, unusual patterns of NLPHL, the spectrum of aggressive B cell lymphomas other than DLBCL, lymphomas with plasmablastic morphology |
| 2021 | Philadelphia | Transformation and transdifferentiation in hematolymphoid malignancies | |||
| 2022 | Florence | Novel frontiers in molecular diagnosis of myeloid neoplasms: biomarkers and integrative prognostic models in myeloid diseases | •Paediatric myeloid neoplasms and related diseases
•AML of ambiguous lineage and other cases of acute leukaemia hard to classify •Adult myelofibrotic myeloid neoplasms |
Novel frontiers in molecular diagnosis of lymphoma and emerging disease entities | Provisional and emerging disease entities
|
| 2023 | Houston | Progress in T- and NK-cell Lymphomas/Leukemias | |||
| 2024 | Dubrovnik | · Organization of the stem-, committed- and precursor-cell bone marrow populations: lessons learned from myeloid and lymphoid precursor cell neoplasms and mixed phenotype acute leukemias”:
· “State-of-the-art: hemophagocytic lymphohistiocytosis – pathogenesis and pathology” Invited speaker: · “Myeloid neoplasms: from hematology and pathology dogmas to hierarchic molecular genetics” |
· Reactive and therapy induced bone marrow changes linked to systemic infectious and non-infectious disorders and MAS/HLH
· Myeloid neoplasms with evidence of the additive and/or cumulative effect of molecular genetic alterations that have “paved the way” to a specific disease category, subcategory or entity · Myeloid and lymphoid early/undifferentiated precursor cell neoplasms and mixed phenotype acute leukemias |
Novel Mechanisms in Lymphomagenesis | Exploring the boundaries of reactive and neoplastic lymphoproliferations
|
| 2025 | Cincinnati | Hematopathology in the Pediatric and Young Adult Population |